Our data demonstrate that tumour-induced Th17 cells progressively transdifferentiate into IL-17A+Foxp3+ and ex-Th17 IL-17AnegFoxp3+ T cells during tumour development. The gene discussed is FOXP3; the disease is neoplasm.